Posts by admin

ASCO Highlights New Drugs, ISPOR How They’ll Be Paid For

Posted on Jun 11, 2012 in Cost/Comparative Effectiveness, Health Technology Assessments, Medical Innovation, Payers: Commercial, Payers: Managed Medicaid/Medicare, Payment Reform, Personalized Medicine, Pharmaceuticals, Pricing, Value-based pricing

  It was perhaps a sign of the changing — but not changed — times that last week’s ASCO meeting, highlighting the next-generation of promising new cancer drugs, overlapped almost perfectly...

Learn More